Sandy Spring Bank Biogen Inc. Transaction History

Sandy Spring Bank

$2.42 Billion
Q4 2024

A detailed history of Sandy Spring Bank transactions in Biogen Inc. stock. As of the latest transaction made, Sandy Spring Bank holds 115 shares of BIIB stock, worth $16,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115

Previous 125 8.0%

Holding current value

$16,086

Previous $24,000 29.17%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$146.47 - $191.55 $1,464 - $1,915	-10 Reduced 8.0%	115 $17,000
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $2,120 - $2,677	10 Added 8.7%	125 $26,000
Q4 2020 Feb 03, 2021	SELL	$236.26 - $355.63 $4,016 - $6,045	-17 Reduced 12.88%	115 $28,000
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $2,118 - $2,445	8 Added 6.45%	132 $38,000
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $2,419 - $3,069	9 Added 7.83%	124 $39,000
Q4 2019 Feb 06, 2020	SELL	$220.06 - $304.07 $11,003 - $15,203	-50 Reduced 30.3%	115 $34,000
Q3 2019 Nov 01, 2019	BUY	$217.44 - $243.88 $10,872 - $12,194	50 Added 43.48%	165 $39,000
Q1 2019 May 06, 2019	SELL	$216.71 - $338.96 $5,417 - $8,474	-25 Reduced 17.86%	115 $27,000
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $15,193 - $18,107	-59 Reduced 29.65%	140 $41,000
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $2,341 - $3,311	-9 Reduced 4.33%	199 $54,000
Q4 2017 Feb 02, 2018	BUY	$307.64 - $344.58 $13,536 - $15,161	44 Added 26.83%	208 $67,000
Q3 2017 Nov 03, 2017	SELL	$281.15 - $329.69 $3,654 - $4,285	-13 Reduced 7.34%	164 $52,000
Q2 2017 Aug 11, 2017	BUY	N/A	177	177 $49,000

Others Institutions Holding BIIB

# of Institutions

1,000

Shares Held

131M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account

Sandy Spring Bank Biogen Inc. Transaction History